Market revenue in 2021 | USD 103.3 million |
Market revenue in 2028 | USD 290.2 million |
Growth rate | 15.9% (CAGR from 2021 to 2028) |
Largest segment | Software |
Fastest growing segment | Services |
Historical data | 2016 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Software, Services |
Key market players worldwide | Certara Inc Ordinary Shares, Dassault Systemes SE, Avantium NV, Simulations Plus Inc, Schrodinger Inc Ordinary Shares, Chemical Computing Group, Physiomics, Rosa & Co, Genedata AG, Instem, Yokogawa Electric Corp., Immunetrics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biosimulation market will help companies and investors design strategic landscapes.
Software was the largest segment with a revenue share of 69.41% in 2021. Horizon Databook has segmented the UK biosimulation market based on software, services covering the revenue growth of each sub-segment from 2016 to 2028.
Increasing research incorporating biosimulation as a drug development tool is expected to drive the market growth in the country. The key purpose is to integrate multiple areas such as pathology, ethnography, computer graphics, & medical imaging and evaluate the chances of success that fulfills the needs of both health services and individual researchers.
According to NIHR, there has been a small increase in the number of clinical trials that have been conducted in the country. There have been significant improvements in regulatory framework for attracting industry players. Increasing number of clinical research activities and improvements in regulatory framework are expected to boost the market growth during the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the UK biosimulation market , including forecasts for subscribers. This country databook contains high-level insights into UK biosimulation market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account